It's considered a research peptide supplement, not a medication
The rapid increase in muscle mass can outpace tendon and ligament adaptation , increasing the risk of soft tissue injuries
The circulating half-life of endogenous amylin is short, with human studies indicating a half-life of 70% [108,109,110]
"Almost everything else is rodent work." Patricia Brubaker, a professor emeritus of physiology at the University of Toronto, has taken a hard look at the research and has come to a similar conclusion about BPC-157's alleged benefits
At the same time, inflammatory infiltration was noticeably reduced
To truly address each patient's needs, we need therapies with different mechanisms of action so that each person can receive the treatment that offers the best balance of effectiveness and tolerability for them," said Liana K